Physician profile
Saima Khalid
NPI 1811294606
$911.06
in general payments reported to CMS, 2019-2025
20 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $187 · 2023: $209 · 2024: $173 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704 · Entertainment: $19.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.43 |
| Entertainment | $19.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $130.43 | 2024-2025 | Repatha, Otezla, Otezla |
| Kci USA, INC. | $114.73 | 2023 | V.A.C. Veraflo |
| Novo Nordisk INC | $91.53 | 2023-2024 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $69.86 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $67.65 | 2024-2025 | Airsupra |
| Abiomed | $52.90 | 2022 | |
| Abbvie INC. | $44.81 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $43.63 | 2022-2023 | Livalo, Seglentis |
| Lucid Diagnostics INC. | $40.43 | 2024 | |
| Dexcom, INC. | $39.82 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $36.46 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $33.88 | 2022 | |
| Horizon Therapeutics Plc | $23.05 | 2022 | |
| Corcept Therapeutics | $20.10 | 2025 | Korlym |
| Optos, INC. | $19.70 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $19.64 | 2025 | Injectafer |
| Paratek Pharmaceuticals, INC. | $18.40 | 2022 | |
| Intra-Sana Laboratories | $16.81 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Lilly USA, LLC | $14.36 | 2025 | Zepbound, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saima Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.